Persky, D. O., Miller, T. P., Unger, J. M., Spier, C. M., Puvvada, S., Stea, B. D., . . . Fisher, R. I. (2015). Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313. Blood.
Citação norma ChicagoPersky, Daniel O., et al. "Ibritumomab Consolidation After 3 Cycles of CHOP Plus Radiotherapy in High-risk Limited-stage Aggressive B-cell Lymphoma: SWOG S0313." Blood 2015.
Citação norma MLAPersky, Daniel O., et al. "Ibritumomab Consolidation After 3 Cycles of CHOP Plus Radiotherapy in High-risk Limited-stage Aggressive B-cell Lymphoma: SWOG S0313." Blood 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.